Rare Neoplasm — Trials

Rare Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 144 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03779854	Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant	active not recruiting	Phase 2	45	Fred Hutchinson Cancer CenterOTHER	1	Sep 25, 2026	clinicaltrials
NCT04910685	(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis	recruiting	Phase 2 / Phase 3	534	Blueprint Medicines CorporationINDUSTRY	23	Sep 23, 2026